Apretude is a medicine approved by the FDA in 2021 to reduce the risk of contracting HIV through sexual contact, also known as pre-exposure prophylaxis (PrEP). PrEP is used to prevent the transmission ...

Apretude is a long-acting injectable medication used to prevent HIV (human immunodeficiency virus) infection in adults and some children who are at high risk of contracting the virus. Apretude is ...

Apretude (cabotegravir extended-release injectable suspension) is a prescription drug used to help prevent HIV. Apretude can cause side effects that range from mild to serious. Examples include ...

Given as few as six times per year and demonstrated superior efficacy to a daily oral PrEP option (FTC/TDF tablets) in reducing the risk of HIV acquisition Approved in the US for use in adults and ...